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ABSTRACT
Centrosomes are the primary microtubule-organizing centers that are important for mitotic 
spindle assembly. Centrosome amplification is commonly observed in human cancer cells and 
contributes to genomic instability. However, it is not clear how centrosome duplication is 
dysregulated in cancer cells. Here, we report that ATAD5, a replisome protein that unloads 
PCNA from chromatin as a replication factor C-like complex (RLC), plays an important role in 
regulating centrosome duplication. ATAD5 is present at the centrosome, specifically at the base of 
the mother and daughter centrioles that undergo duplication. UAF1, which interacts with ATAD5 
and regulates PCNA deubiquitination as a complex with ubiquitin-specific protease 1, is also 
localized at the centrosome. Depletion of ATAD5 or UAF1 increases cells with over-duplicated 
centrosome whereas ATAD5 overexpression reduces such cells. Consistently, the proportion of 
cells showing the multipolar mode of chromosome segregation is increased among ATAD5- 
depleted cells. The localization and function of ATAD5 at the centrosomes do not require other 
RLC subunits. UAF1 interacts and co-localizes with ID1, a protein that increases centrosome 
amplification upon overexpression. ATAD5 depletion reduces interactions between UAF1 and 
ID1 and increases ID1 signal at the centrosome, providing a mechanistic framework for under-
standing the role of ATAD5 in centrosome duplication.
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Centrosomes are the primary microtubule orga-
nizing center and important for bipolar spindle 
assembly during mitosis [1]. A centrosome is com-
posed of two centrioles, a mother and a daughter 
centriole. The mother centriole is a mature cen-
triole capable of forming the pericentriolar matrix 
which is a microtubule organizing center while the 
daughter centriole has no such abilities. In divid-
ing cells, both these centrioles are disengaged, 
duplicated, separated, and moved to opposite 
poles to form a bipolar spindle in a timely fashion 
that is coordinated with the cell cycle [2]. This 
centrosome cycle consists of several structural 
and functional transitions that are regulated by 
changes in expression level and post-translational 
modification of participating proteins [3]. 
Consequently, defects in regulation lead to centro-
some aberrations, usually increase centrosome 
numbers, and contribute to chromosome 
instability, which is related to diseases, especially 
cancers [4,6]. However, it is still not clearly under-
stood how centrosomes are dysregulated in cancer 
cells.
Centrosomal localization and non-replicative 
roles for the DNA replication-related proteins 
have been reported. ORC1, a subunit of the origin 
recognition complex (ORC), prevents Cyclin 
E-dependent reduplication of both centrioles and 
centrosomes in a single cell cycle [7]. ORC2 also 
localizes to centrosomes, even though its actual 
role at centrosomes has not yet been investigated 
[8]. Cdc6, a DNA replication licensing factor, 
negatively regulates centrosome duplication by 
inhibiting spindle assembly abnormal protein 6 
(Sas-6) which is a cartwheel protein [9]. The 
expression of a subunit of replicative MCM heli-
case, MCM5, but not MCM2, significantly inhibits 
over-duplication of centrosomes [10]. In addition, 
TopBP1, a protein critical for DNA replication and 
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DNA damage response, is localized at the centro-
some and is required for proper mitotic progres-
sion [11].
Inhibitor of DNA Binding 1 (ID1) is a helix-loop- 
helix protein that inhibits the transcriptional activa-
tion ability of basic helix-loop-helix proteins [12]. It 
has been previously reported that a portion of ID1 is 
localized at the centrosome and ectopic expression of 
ID1 results in supernumerary centrosomes [13]. 
High expression levels of ID1 consistently correlate 
with centrosomal abnormalities in human tumor 
cells [14]. A strong binding of ID1 to the proteaso-
mal subunit S5A/Rpn10 and stabilization of Aurora 
A kinase through Cdh1 binding have been suggested 
as causes of centrosomal abnormalities [15,16]. 
A Previous study reported that overexpression of 
ubiquitin-specific protease 1 (USP1) increases ID1 
expression, leading to centrosome duplication [17]. 
Although stabilization of ID proteins by USP1- 
mediated deubiquitination has been reported as 
a mechanism underlying the maintenance of the 
stem cell-like state [18], it is still not clear how ID1 
is dysregulated in cancer cells.
ATAD5 forms a pentameric complex, similar to 
the clamp loader complex (replication factor C, 
RFC), that consists of ATAD5 and RFC2-5, referred 
to as ATAD5-RFC-like complex (RLC) [19,25]. 
ATAD5-RLC is important for maintaining genomic 
stability in eukaryotic organisms, from yeasts to 
humans and the importance of this function is 
underscored by the fact that Atad5 heterozygote 
mutant mice develop tumors [26]. Additionally, 
somatic mutations of ATAD5 were found in 
patients with several types of cancers and 
a genome-wide analysis indicated that the ATAD5 
locus confers enhanced susceptibility to endome-
trial, breast, and ovarian cancers [26,28]. A recent 
study revealed that ATAD5 promotes replication 
fork restart under replication stress [29]. ATAD5- 
RLC has two major molecular functions in the 
regulation of the replication sliding clamp, prolifer-
ating cell nuclear antigen (PCNA), at the replication 
forks: (1) PCNA unloading during normal DNA 
replication to terminate DNA synthesis [30,33]. 
(2) PCNA deubiquitination to limit the DNA 
damage bypass pathway by recruiting the USP1/ 
USP1-associated factor 1 (UAF1) complex [34].
UAF1 forms distinct complexes with various pro-
teins, such as USP1, USP12, USP46, RAD51AP1 and 
FANCI [34,38]. UAF1 has been reported to be an 
important factor for the stability and catalytic activ-
ity of USP1 [37]. USP1 regulates DNA damage tol-
erance pathway and the Fanconi anemia pathway 
through its association with UAF1 and by deubiqui-
tinating PCNA and FANCD2, respectively [37]. The 
USP1/UAF1 complex has also been reported to par-
ticipate in homologous recombination [35,38,39]. 
However, not much has been studied regarding the 
roles of the USP1/UAF1 complex in centrosome 
regulation. Since USP1 affects centrosome duplica-
tion and ATAD5 interacts with the USP1/UAF1 
complex [17,34], we hypothesized that ATAD5 
plays a role in centrosome duplication. In this 
study, we found that ATAD5 and UAF1 are localized 
at the centrosome and play important roles in reg-
ulating centrosome duplication and bipolar segrega-
tion. UAF1 interacts with ID1 and their interaction 
is altered according to ATAD5 protein level. 
Consistent with centrosome over-duplication in 
ATAD5-depleted cells, ID1 signals are increased at 
the centrosomes. Our results strongly suggest that 
ATAD5 is involved in controlling centrosome dupli-
cation by modulating ID1 levels at the centrosomes.
Materials and methods
Cell lines
Human embryonic kidney (HEK) 293 T, HeLa, 
U2OS, and NIH3T3 cells were cultured in 
Dulbecco’s modified Eagle’s medium (DMEM) sup-
plemented with 10% fetal bovine serum (GE 
Healthcare) or 10% calf serum (GE Healthcare) for 
NIH3T3 cells, 100 U/mL penicillin G (Life 
Technologies), and 100 μg/mL streptomycin (Life 
Technologies) at 5% CO2, 37°C. HeLa cells expres-
sing green fluorescence protein (GFP)-tagged 
Centrin1 (HeLa_Centrin1-GFP) were generated by 
infection of lentiviral vector pMF1454. AB2.2 mouse 
embryonic stem cells (mESCs) were maintained in 
M15 medium (high-glucose DMEM supplemented 
with 15% fetal bovine serum, 100 μM mercaptoetha-
nol, 1 mM glutamine, 3 mg/ml penicillin, 5 mg/ml 
streptomycin) containing 1,000 U/ml ESGRO 
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leukemia inhibitory factor. Atad5 knockout AB2.2 
mESCs were generated using CRISPR-mediated 
gene targeting. Briefly, cells were electroporated 
with two guide RNAs (pX330, Addgene plasmid 
number 42,230) which target sequences in 5ʹ of 
mouse Atad5 exon2 (guide RNA #1: 5ʹ- 
GTTGTACGCCTTTGTCGATTG-3ʹ and guide 
RNA #2: 5ʹ- GACTAAACCTTCCCTAGCTG-3ʹ) 
coupled with the targeting vector and selected in 
HAT media (0.5 mM sodium hypoxanthine, 2 μM 
aminopterin, 80 μM thymidine) before colony pick-
ing. ATAD5 knockout U2OS cell line was generated 
using a commercial ATAD5 CRISPR/CAS9 knock-
out plasmid (Santa Cruz biotechnology; SC-405,654) 
with the manufacturer’s protocol. Briefly, U2OS cells 
were transfected with the CRISPR/CAS9 plasmid, 
and 48 h later GFP positive single cells were sorted 
using a FACSAria cell sorter (BD biosciences). After 
3 wk, single-cell colonies were picked and tested for 
complete ATAD5 knockout using immunoblotting.
Drugs and antibodies
The following drug was used in this study: CDK1 
inhibitor (RO3306; Sigma-Aldrich). The following 
antibodies were used: anti-UAF1, anti-Centrin2, anti- 
RFC5, anti-CEP164 (Santa Cruz Biotechnology); anti- 
FLAG, anti-HA, anti-γ-tubulin, anti-α-tubulin 
(Sigma-Aldrich); anti-NUF2 (Abcam); anti-histone 
H3 antibodies (Thermo Fisher Scientific). Polyclonal 
anti–human ATAD5 antibody was raised against the 
N-terminal fragment (residues 202–367 amino acids) 
in rabbits. The anti-ATAD5 antibody was purified 
using ATAD5 fragment (residues 1–400 amino 
acids) blotted to nitrocellulose membrane. Briefly, 
the blot was incubated with 5 mL of serum, washed 
three times with Tris-buffered saline containing 0.1% 
Tween 20. Then, the bound antibody was eluted with 
0.1 M glycine buffer (pH 2.7) three times, and the 
eluted antibody was neutralized with 1/10 volume of 
1.5 M Tris (pH 8.8).
Transfections and RNA interference
Transfections of plasmid DNA and small interfer-
ing RNAs (siRNAs, 20 nM) were performed using 
X-tremeGENE™ HP (Roche) and RNAiMAX 
(Thermo Fisher Scientific) respectively, according 
to the manufacturer’s instructions. Transfection 
reagent was removed 6 h post transfection and 
fresh medium was added. Cells were analyzed 
48 h after transfection. The siRNA sequences 
used in this study were: ATAD5 3ʹ UTR (5ʹ- 
GUAUAUUUCUCGAUGUACA-3ʹ); UAF1 (5ʹ- 
AAUCAGCACAAGCAAGAUCCAUAUA-3ʹ); RF 
C4 (5ʹ-AAGAGAUUAGGAAGAUCUG-3ʹ).
Immunoprecipitation and immunoblot analysis
For immunoprecipitation, cells were lysed in ice- 
cold buffer X (100 mM Tris-HCl, 250 mM NaCl, 
1 mM EDTA, 1% NP-40, 0.1 M PMSF) with phos-
phatase inhibitors (Roche), protease inhibitors 
(Roche) and Benzonase nuclease (250 U/mL) fol-
lowed by sonication and centrifugation. Target 
proteins within the lysate were immunoprecipi-
tated with specific antibodies. For chromatin- 
bound fraction, Triton X-100 insoluble fractions 
were obtained according to the methods described 
previously [31] with slight modifications. In brief, 
cells were incubated with buffer A (100 mM NaCl, 
300 mM sucrose, 3 mM MgCl2, 10 mM PIPES (pH 
6.8), 1 mM EGTA, 0.2% Triton X-100) containing 
phosphatase inhibitors and protease inhibitors for 
5 min on ice followed by centrifugation. Then, the 
chromatin-bound fraction was isolated by resus-
pending the pellet in RIPA buffer (50 mM Tris- 
HCl pH 8.0, 150 mM NaCl, 5 mM EDTA, 1% 
Triton X-100, 0.1% sodium dodecyl sulfate, 0.5% 
sodium deoxycholate) containing 0.1 M PMSF, 
phosphatase inhibitors, protease inhibitors, and 
Benzonase nuclease for 30 min on ice followed 
by sonication and centrifugation. For whole cell 
extracts, cells were incubated in RIPA buffer with 
Benzonase nuclease for 10 min on ice followed by 
sonication and centrifugation.
For immunoblot analysis, proteins were sepa-
rated by SDS-PAGE and transferred to 
a nitrocellulose membrane. Membranes were incu-
bated in Tris-buffered saline containing 0.1% 
Tween 20 supplemented with 5% skim milk pow-
der for blocking. Membranes were then incubated 
with primary antibodies overnight. After washing, 
the blot was incubated with horseradish 
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peroxidase-conjugated secondary antibodies (Enzo 
Life Sciences). Signals were detected using 
enhanced chemiluminescence reagent (Thermo 
Fisher Scientific) and an automated imaging sys-
tem (ChemiDoc™; Bio-Rad Laboratories).
Flow cytometry
Cells were washed with PBS, fixed with 70% etha-
nol for 1 h, and then incubated with 0.1 mg/mL 
RNase A at 37°C for 1 h. DNA was stained with 
0.05 mg/mL propidium iodide. Flow cytometry 
was performed on a FACSVerse™ flow cytometer 
using BD FACSuite™ software (BD Biosciences). 
Data analysis was performed using FlowJo 
software.
Immunostaining
U2OS, HeLa, and NIH3T3 cells were plated on 
LabTek™ chamber slides (Thermo Fisher 
Scientific), and mESCs were plated on μ-Slide 
(ibidi). Cells were pre-extracted with CSK buffer 
(10 mM PIPES, 100 mM NaCl, 300 mM sucrose, 
3 mM MgCl2, 1 mM EGTA, and 0.5% Triton 
X-100) for 10 min at 4°C and fixed with 4% 
paraformaldehyde for 20 min at room tempera-
ture. The fixed cells were incubated with the pri-
mary antibodies diluted in PBS supplemented with 
10% fetal bovine serum for 1 h at room tempera-
ture. After three washes with 0.05% Triton X-100 
in PBS, Alexa Fluor®–conjugated secondary anti-
bodies (Thermo Fisher Scientific) were added and 
incubated for 30 min. Cells were mounted using 
ProLong® Gold antifade reagent with DAPI 
(Vector Laboratories).
Image acquisition and analysis
Confocal images were acquired using LSM880 
confocal microscope (Carl Zeiss) with 40x/1.2 
lens objective. For all centrosome counting experi-
ments, whole cell depth was covered by z-stack 
imaging method. Z-stack images were then com-
bined by “maximum intensity projection” analysis 
method in “Zen 2.6 blue edition” (Carl Zeiss) 
software. For ID1 intensity analysis, each centriole 
was firstly masked and ID1 intensity within the 
masked regions was measured. This signal was 
then normalized by the size of the centriole.
Structural illumination images were acquired 
using a Zeiss ELYRA S.1 microscope (Carl Zeiss) 
with Plan-Apochromat 63x/1.4 Oil DIC. Green 
(488 nm) and Red (561 nm) channels were 
acquired by sequentially alternating the excitation 
whilst retaining the same setting with respect to 
phase, rotation, and multi-cube filterset. Images 
were acquired with five phases, five rotations. 
Green channel signal was acquired with a grating 
of 28.0 μm and red was 34.0 μm. Images were 
processed using the automatic reconstruction set-
tings in the Zen software.
Statistical analysis
Prism 8 (GraphPad Software) was used to generate 
graphs and analyze data. For all data, two-tailed 
paired Student’s t-test was used; * p ≤ 0.05, ** 
p ≤ 0.01, ns, not significant. Statistical parameters 
are described in the figures and the figure legends.
Results
ATAD5 is localized at the centrosomes without 
forming an RLC complex
ATAD5 plays an important role at replication forks 
as a replisome protein [30,31,33]. Several replisome 
proteins have been reported to have additional, repli-
cation-independent roles. To investigate possible 
roles of ATAD5 in other cellular processes, we 
immunostained endogenous ATAD5 and visualized 
its cellular localization. ATAD5 signals were 
observed as small focal forms throughout the 
nucleus in U2OS human osteosarcoma cell line 
(Figure 1(a)). Interestingly, one or two large focal 
signals adjacent to each other have been observed at 
the nucleus edge or in the cytoplasmic region close to 
the nucleus. Since the numbers and locations of these 
focal signals were similar to those of centrosomes, 
cells were co-immunostained with antibodies to 
ATAD5 and γ-tubulin, which is a marker for centro-
somes. We found that the large focal signals of 
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ATAD5 were co-localized with either of the two γ- 
tubulin signals. The co-localization of ATAD5 and 
γ-tubulin was also observed in NIH3T3 cells, which 
is a mouse fibroblast cell line (Figure 1(b)) and in 
mouse embryonic stem cells (mESCs) (Figure 1(c)). 
These signals were completely missing in Atad5- 
knockout mESCs. These results indicate that the 
anti-ATAD5 antibody that we used specifically 
detects endogenous ATAD5. Additionally, when 
mNeonGreen-fused ATAD5 N-terminal domain 
Figure 1. ATAD5 is localized at the centrosomes in an RFC independent manner.
(a) U2OS cells and (b) NIH3T3 cells were fixed at asynchronous condition for immunostaining. Bar, 5 μm. (c) The wild type (Atad5+/+) 
mouse embryonic stem cells (mESCs) and Atad5 knock out (Atad5−/-) mESCs were fixed for immunostaining. Bar, 5 μm. The inset 
shows high-magnification image of the centrosome. Bar, 2 μm. (d) U2OS cells were transfected with a DNA vector expressing 
mNeonGreen-fused ATAD5 N-terminal fragment (1–693 amino acids). After 48 h of transfection, cells were fixed for immunostaining 
as indicated. Bar, 5 μm. (e) HeLa cells stably expressing GFP-tagged Centrin1 (HeLa_Centrin1-GFP) were fixed at asynchronous 
condition for immunostaining. The arrow indicates a centrosome. Bar, 5 μm. The inset shows high-magnification image. Bar, 1 μm. 
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was expressed in cells, mNeonGreen signals were co- 
localized with γ-tubulin signals (Figure 1(d)), which 
further supports our finding that ATAD5 is localized 
at the centrosomes.
ATAD5 regulates PCNA at replication forks as 
a pentameric complex, ATAD5-RLC [32]. We 
examined whether ATAD5 localizes at the centro-
some as a component of ATAD5-RLC by doing 
co-immunostaining of RFC5 protein, a small sub-
unit of RLC. To visualize centrioles, we generated 
HeLa cells that constitutively express green fluor-
escence protein (GFP)-tagged Centrin1, a centriole 
protein (HeLa_Centrin1-GFP). RFC5 was 
observed throughout the nucleus as a punctate 
signal. However, unlike ATAD5, RFC5 did not co- 
localize with Centrin1 (Figure 1(e)). These results 
suggest that the localization of ATAD5 at the 
centrosome does not require the formation of the 
ATAD5-RLC complex.
ATAD5 is localized at the base of mother and 
daughter centrioles that undergo duplication
After disengagement of the mother and daughter 
centrioles, the pericentriolar matrix containing γ- 
tubulin ring complexes (γ-TuRCs) are recruited to 
the centrioles and surround them [1,2]. Since the 
large focal signals of ATAD5 were co-localized 
with either one or both of the γ-tubulin signals 
(Figure 1(a)), we further examined the co- 
localization of these two proteins at the centro-
somes. ATAD5 signals were co-localized with two 
adjacent γ-tubulin signals with three different pat-
terns. One of the two γ-tubulin signals always co- 
localized with ATAD5 signal, but the other 
showed no (i), intermediate (ii) or strong (iii) 
ATAD5 signal (Figure 2(a)). When we examined 
the co-localization of ATAD5 and Centrin2, 
a centriole protein, we obtained a similar pattern 
in general but structurally somewhat different 
results. ATAD5 signal was co-localized with one 
of the two adjacent Centrin2 signals (i, before 
maturation of daughter centriole) or both sepa-
rated Centrin2 signals (ii, after centrosomal cohe-
sion is lost and two matured centrosomes are 
separated at the G2/M transition) (Figure 2(b)). 
In both cases, however, the ATAD5 and Centrin2 
signals were visually separated without overlap-
ping. The conventional confocal microscopy was 
not enough to resolve the centriole pairs (Figure 2 
(b)). Therefore, we used a structured illumination 
microscopy to obtain high-resolution images of 
ATAD5 and centriole pairs. We could observe 
clearly discernible one or two centriole pairs 
(Figure 2(c)). We observed ATAD5 signals right 
beside a pair of Centrin1 signals. Considering the 
structure of a centriole pair, we concluded that 
ATAD5 is localized at the base of centriole pairs.
Since ATAD5 signals are detected only at 
a single centrosome in some cells (Figure 2(a)), 
we hypothesized that ATAD5 is localized only at 
the mother centriole upon centriole disengage-
ment and expands its localization at the daughter 
centriole as it matures. To test this hypothesis, 
cells were co-immunostained with antibodies to 
ATAD5 and CEP164, a marker for the appendages 
located at the top of the mother centriole. Until 
a daughter centriole matures into a mother cen-
triole, it lacks appendages and CEP164 signal 
would be negative. ATAD5 signals were detected 
next to CEP164 (Figure 2(d)). However, ATAD5 
signals were also detected without an adjacent 
CEP164 signal (Figure 2(d), ii). Immunostaining 
of HeLa_Centrin1-GFP cells with ATAD5 and 
CEP164 spotted ATAD5 at the centrosome in 
a more structurally ordered manner. ATAD5 sig-
nals were detected at the base of the mother cen-
trioles, which is at the opposite end from the 
CEP164 signal (Figure 2(e)). Collectively, we con-
clude that ATAD5 primarily localizes to the 
mother centriole, but also accumulates at the 
daughter centriole even before it fully matures 
into the mother centriole.
ATAD5 depletion results in centrosome 
amplification
To obtain insights into the biological meaning of 
localization of ATAD5 at the centrosomes, we 
examined the effects of ATAD5 depletion on cen-
trosome biology. Since ATAD5 begins to localize 
at the daughter centriole that undergoes duplica-
tion, we first enumerated the centrosomes. To 
more accurately examine the centrosome numbers, 
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we used HeLa_Centrin1-GFP cells. Small interfer-
ing RNA (siRNA)-mediated ATAD5 depletion 
almost doubled the frequency of cells with centro-
some over-duplication (3.05 ± 1.29%) compared to 
non-target siRNA treated cells (1.79 ± 0.95%). We 
then performed ATAD5 recovery experiments. 
Ectopic expression of ATAD5 reduced the fre-
quency of cells with centrosome over-duplication 
to basal levels (1.31 ± 0.30%) (Figure 3(a)), indi-
cating that the effect is ATAD5-specific. We 
obtained similar results with U2OS cells. ATAD5 
depletion doubled the frequency of centrosome 
over-duplication (10.34 ± 2.62%) compared to 
non-target siRNA treated cells (4.38 ± 1.94%) 
(Figure 3(b)).
Prolonged S phase has been reported to cause 
multiple rounds of centrosome duplication in 
a single S phase [40,41]. ATAD5 depletion delays 
S phase progression, [31] which could result in 
centrosome amplification. Therefore, we tested 
the effects of overexpression of ATAD5, which 
does not alter cell cycle profile (data not shown), 
Figure 2. ATAD5 is localized at the base of mother and daughter centrioles that undergo duplication.
(a-e) U2OS cells (A, B, D) and HeLa_Centrin1-GFP cells (c, e) were fixed at asynchronous condition for immunostaining as indicated. 
Bar, 1 μm. Images were acquired using a confocal microscope (a, b, d, e) or a structured illumination microscopy (c). 
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on centrosome number. ATAD5 overexpression 
reduced the frequency of cells with centrosome 
amplification to 1.2 ± 0.99% compared to control 
cells (2.4 ± 1.23%) (Figure 3(c)), suggesting that 
a small delay in S phase progression by ATAD5 
depletion is not the cause of centrosome amplifi-
cation. To completely rule out the effect of S phase 
delay upon ATAD5 depletion, we arrested cells at 
Figure 3. Centrosomes are over-duplicated in ATAD5-depleted cells.
(a-c, e-g) 48 h after transfection of siRNA or cDNA as indicated, cells were immunostained with an anti-γ-tubulin antibody. The 
percentage of cells with more than two centrosomes was displayed. Three independent experiments were performed and at least 
300 cells were counted per experiment. Values represent mean ± SEM. Statistics: paired t-test. *, p ≤ 0.05, **, p ≤ 0.01, ns, not 
significant. (a-c, g) The right panels of graphs show immunoblot results from whole cell extracts prepared 48 h after transfection. (d, 
e) Cells were treated with 2 ug/mL aphidicolin (APH) for 24 h to arrest cells at the G1/S phase boundary. (d) Cells were fixed and 
DNA was stained with propidium iodide for cell cycle analysis. 
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the G1/S boundary using polymerase α inhibitor, 
aphidicolin, which is commonly used for centro-
some duplication studies (Figure 3(d)). We found 
that ATAD5 depletion increased centrosome over- 
duplication even when cells were arrested at the 
G1/S boundary (Figure 3(e)). Overexpression of 
Aurora A kinase or ID1 has been reported to 
cause an increase in cells with centrosome over- 
duplication [13,16,42]. The level of defects caused 
by overexpression of Aurora A kinase or ID1 in 
our experimental conditions (figure 3(f)) was com-
parable to that caused by ATAD5 depletion, which 
suggests that the observed effects of ATAD5 deple-
tion on centrosome numbers are significant.
We also tested whether small subunits of RLC 
were involved in centrosome duplication. In line 
with our previous finding that ATAD5 is localized 
at centrosomes without forming an RLC complex 
(Figure 1(e)), RFC4 depletion did not affect the 
frequency of cells with centrosome amplification 
(Figure 3(g)). Taken together, these results suggest 
that ATAD5 is important for the proper regulation 
of centrosome duplication and this regulation is 
independent of RLC formation.
ATAD5 depletion results in multipolar 
segregation
Centrosomes mediate mitotic microtubule organi-
zation. A pair of centrosomes is pulled to the 
opposite poles and drives stable bipolar segrega-
tion of chromosomes to facilitate correct cell divi-
sion. Therefore, over-duplicated centrosomes or 
fragmented centrosomes often cause multipolar 
segregation leading to abnormal distribution of 
chromosomes [2]. Since ATAD5 depletion results 
in supernumerary centrosomes (Figure 3), we 
speculated that it would eventually lead to an 
increase in cells with multipolar segregation. 
Cells were co-immunostained with antibodies to 
α-tubulin and NUF2, a centromere protein, to 
clearly visualize chromosome segregation. As 
expected, ATAD5-depleted U2OS cells showed 
significantly increased events of multipolar segre-
gation (4.48 ± 2.09%) compared to the control 
cells (1.89 ± 0.31%) (Figure 4(a,b)). Furthermore, 
this phenotype was consistently observed in HeLa 
cells (Figure 4(c,d); 1.56 ± 0.28% vs. 5.72 ± 0.53%) 
and ATAD5 knockout U2OS cells (Figure 4(e); 
2.81 ± 0.31% vs. 8.01 ± 0.71%). Apart from the 
defects in multipolar segregation, we did not 
observe any significant defects in centriole or 
microtubule orientation in ATAD5-depleted cells 
(Figure 4(c)). Even in ATAD5-depleted cells that 
undergo multipolar segregation, there were two 
centrioles at each pole and were focused at micro-
tubule minus ends (Figure 4(c)). However, our 
findings clearly suggest that ATAD5 is required 
for accurate centrosome duplication and is further 
responsible for correct bipolar segregation.
UAF1 and ID1 interact, and co-localize at the 
centrosomes
Since ATAD5 interacts with the USP1/UAF1 com-
plex and USP1 has been reported to regulate cen-
trosome duplication by increasing ID1 levels 
[17,34], we speculated that ATAD5 modulates 
ID1 to regulate centrosome duplication. We first 
tested whether ATAD5 physically interacts with 
ID1. When we immunoprecipitated ATAD5 or 
ID1, we could not detect either proteins in immu-
noprecipitates from each pull-down assay (data 
not shown). Instead, we found that UAF1, 
a strong interacting partner of ATAD5 and 
USP1, interacted with ID1. FLAG-tagged UAF1 
was immunoprecipitated with HA-tagged ID1 
(Figure 5(a)). This interaction was also confirmed 
by pulling down HA-tagged ID1 (Figure 5(b)). It 
has been previously reported that UAF1 stabilizes 
USP1 in vitro [37] and that USP1 increases ID1 
protein levels [18]. However, the protein levels of 
USP1 and ID1 were not affected by UAF1 over-
expression in our experimental conditions (Figure 
5(a)). We also found that the protein levels of 
USP1 and ID1 were not affected by UAF1 deple-
tion (Figure 5(c)). Different from the previous 
studies where gene knockout or small hairpin 
RNA was used to deplete UAF1 [35,39,43], tran-
sient depletion by siRNA does not appear to 
decrease USP1 levels.
We also examined the centrosomal localization 
of ID1 and UAF1 proteins. HA-tagged ID1 was 
co-localized with Centrin1 (Figure 5(d)), as 
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Figure 4. Bipolar segregation is defective in ATAD5-depleted cells.
(a-d) U2OS cells (a, b) or HeLa_Centrin1-GFP cells (c, d) were transfected with ATAD5 siRNA for 48 h before fixation for 
immunostaining. (e) Wild type or ATAD5 knockout U2OS cells were fixed for immunostaining. (a-e) Cells were arrested at the G2 
phase by treatment of 10 μM RO3306, a CDK1 inhibitor, for 20 h and released in the fresh media for 1 h (a, b) and 1.5 h (c, d, e) 
before fixation. (a, c) Representative images. Bar, 20 μm (a) and 5 μm (@). (b, d, e) The percentage of cells with multipolar 
segregation was displayed. Three independent experiments were performed and at least 100 cells were counted per experiment. 
Values represent mean ± SEM. Statistics: paired t-test. *, p ≤ 0.05. (e) The right panel of graph shows immunoblot results from 
chromatin-bound protein fraction. 
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Figure 5. UAF1 and ID1 interact, and co-localize at the centrosome.
(a, b) HEK293 T cells were transfected with 3xFLAG-tagged UAF1 cDNA (FLAG-UAF1) and HA-tagged ID1 cDNA (HA-ID1). (a, b) After 
48 h, whole cell extracts were prepared for immunoprecipitation (IP) with an anti-FLAG antibody (A) and an anti-HA antibody (b). 
Immunoprecipitates were eluted, resolved by SDS-PAGE, and immunoblotted using the indicated antibodies. (c) HEK293 T cells were 
transfected with a combination of UAF1 siRNA and HA-ID1 cDNA. After 48 h of transfection, whole cell extracts (WCE) were subjected 
for immunoblotting. (d-f) After 48 h of transfection, cells were fixed for immunostaining as indicated. HeLa_Centrin1-GFP cells (d) 
and HeLa cells (f) were transfected with HA-ID1 cDNA. (e) HeLa cells were transfected with mNeonGreen-fused UAF1 cDNA. Bar, 
5 μm. (g) HeLa_Centrin1-GFP cells were transfected with UAF1 siRNA for 48 h and fixed. The percentage of cells with more than two 
centrosomes was displayed. Three independent experiments were performed. Values represent mean ± SEM. Statistics: paired t-test. 
*, p ≤ 0.05. 
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previously reported [13]. Immunostaining of 
UAF1 showed punctuation signals and one of sig-
nals was co-localized with γ-tubulin (Figure 5(e)). 
However, we could not detect USP1 signals at the 
centrosomes. As expected, co-immunostaining of 
UAF1 and ID1 showed co-localization of the two 
proteins (figure 5(f)). Interestingly, UAF1 deple-
tion increased the frequency of cells with centro-
some amplification (2.36 ± 0.29%) compared to 
non-target siRNA treated cells (1.47 ± 0.46%) 
(Figure 5(g)). These data suggest that the interre-
lationship between ATAD5, UAF1, and ID1 is 
important for centrosome regulation and that the 
effect of ATAD5 depletion on centrosome dupli-
cation is not mediated by changes in USP1 and 
ID1 protein levels.
ATAD5 regulates interactions between UAF1 and 
ID1
Based on the binding of UAF1 with both ATAD5 
and ID1, we investigated whether ATAD5 is 
required for the interaction between UAF1 and 
ID1 proteins. We found that ATAD5 depletion 
reduced interactions between UAF1 and ID1 in 
whichever ways the proteins were pulled down 
(Figure 6(a,b)). Conversely, overexpression of 
ATAD5 increased interactions between UAF1 
and ID1 proteins (Figure 6(c)). Neither ATAD5 
depletion nor overexpression affected the total 
protein level of ID1 (Figure 6(a-d)). These data 
suggest that ATAD5 regulates interactions 
between UAF1 and ID1 and this regulatory 
mechanism for ID1 is different from USP1- 
mediated ID1 regulation.
ATAD5 depletion increases ID1 signals at the 
centrosomes
Next, we checked the effects of ATAD5 depletion 
on ID1 at the centrosomes. We measured the 
mean intensities of ID1 signals at the centrioles 
and normalized them by numbers and sizes of 
centrioles. We found that ID1 signals, specifically 
at the centrosomes, were increased in ATAD5- 
depleted cells compared to control cells (Figure 7 
(a and b)), and this was consistent in ATAD5 
knockout U2OS cells (Figure 7(c and d)). These 
data suggest that ATAD5 modulates the localiza-
tion of ID1 at the centrosomes.
Discussion
We have demonstrated that ATAD5 and UAF1 are 
localized at the centrosomes and that both these 
proteins play important roles in centrosome reg-
ulation. How ATAD5 controls centrosome dupli-
cation and how its dysregulation causes 
centrosome amplification is not yet fully defined, 
but several possibilities are suggested based on 
previous works and our studies. ATAD5 depletion 
increases ID1 signals at the centrosomes (Figure 7 
(a-d)). Since ID1 overexpression has been pre-
viously reported to lead to centrosome amplifica-
tion [13], increased ID1 expression at the 
centrosomes can result in centrosome amplifica-
tion in ATAD5-depleted cells. Deubiquitination 
activity of USP1 has been reported to increase 
ID1 protein levels [17,18]. Although ATAD5 
depletion does not alter protein levels of USP1 
[34], since UAF1 increases USP1 activity [37], it 
is still possible that ATAD5 regulates deubiquiti-
nation activity of USP1 through UAF1. However, 
depletion or overexpression of ATAD5 or UAF1 
did not alter the protein levels of ID1 (Figures 5 
and 6). Collectively, these results indicate that in 
ID1 regulation, ATAD5 appears to use a different 
regulatory mechanism than USP1. Instead, we 
found that ID1 interacts with UAF1 and this inter-
action is mediated by ATAD5 (Figure 6(a-c)). 
However, we could not detect ATAD5 in ID1 
immunoprecipitates (Figure 6(b)). Therefore, it is 
speculated that UAF1 physically interacts with ID1 
under certain conditions, and ATAD5 can pro-
mote their interactions in a temporary manner 
(Figure 7(e, i)). Although relative contributions 
of nuclear UAF1 and centrosomal UAF1 is not 
clear, one conjecture based on the observation 
that ATAD5 depletion increases ID1 levels at the 
centrosomes is as follows; UAF1 sequesters ID1, 
which is promoted by ATAD5, and this conse-
quently inhibits hyper-accumulation of free ID1 
at the centrosomes (Figure 7(e, i)). Therefore, 
ATAD5 depletion releases ATAD5/UAF1-bound 
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ID1, which in turn results in increase of centroso-
mal ID1 localization and centrosome over- 
duplication (Figure 7e, ii). This might explain the 
unaltered levels of total ID1 protein, together with 
altered UAF1/ID1 interactions upon ATAD5 
depletion. Alternatively, ATAD5/UAF1 might 
control centrosomal ID1 levels by direct protein 
binding and its regulatory dysfunction can lead to 
ID1 accumulation.
It is also possible that ATAD5 regulates other 
centrosomal proteins that participate in centriole 
duplication by protein–protein interactions. After 
centriole disengagement, ATAD5 accumulates at 
the base of the daughter centriole before it fully 
matures into the mother centriole (Figure 2(d)). 
This is the period when procentrioles start to form 
and elongate at the base of the mother and daugh-
ter centrioles. Centrosomal proteins that localize at 
the proximal end of the centriole participate in 
centriole duplication and procentriole formation 
processes. Sas-6 promotes procentriole formation 
[44], and it also stabilizes centriole intermediates 
Figure 6. ATAD5 regulates interactions between UAF1 and ID1.
(a-c) HEK293 T cells were transfected with a combination of ATAD5 siRNA, 3xFLAG-tagged UAF1 (FLAG-UAF1) cDNA, MYC-tagged 
ATAD5 (MYC-ATAD5) cDNA, and HA-tagged ID1 (HA-ID1) cDNA. After 48 h, whole cell extracts were prepared for immunoprecipita-
tion (IP) with an anti-FLAG antibody (a, c) and an anti-HA antibody (b). Immunoprecipitates were eluted, resolved by SDS-PAGE, and 
immunoblotted using the indicated antibodies. (d) HEK293 T cells were transfected with MYC-ATAD5 cDNA and HA-ID1 cDNA. After 
48 h, whole cell extracts were resolved by SDS-PAGE and immunoblotted using the indicated antibodies. 
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Figure 7. ATAD5 depletion increases ID1 signals at the centrosomes.
(a-d) HeLa_Centrin1-GFP cells (a, b) or ATAD5 knockout U2OS cells (c, d) were transfected with ATAD5 siRNA and HA-ID1 cDNA for 
48 h and fixed for immunostaining. Bar, 5 μm. (a, c) Representative images. The inset shows high-magnification image. Bar, 2 μm. (b, 
d) Mean HA signal intensities at the centrosome were measured and displayed. Three independent experiments were performed. 
Values represent mean ± SEM. Statistics: paired t-test. *, p ≤ 0.05. (e) A graphical model of how ID1 and UAF1 fit in the regulation of 
centrosome by ATAD5. In normal cells, ATAD5 facilitates interactions between UAF1 andID1 and therefore inhibits free ID1 from 
accumulating at the centrosome. However, in the absence of ATAD5, ID1 is released from UAF1, thereby free ID1 accumulates at 
centrosome, leading to centrosome defects. 
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[45]. Recruitment of Sas-6 to the centrioles is 
promoted by Polo-like kinase 4 (Plk4) and SCL/ 
TAL1 interrupting locus (STIL) [46]. In addition, 
CEP135 interacts with centrosomal 
P4.1-associated protein (CPAP), which regulates 
procentriole formation and its elongation [47,48]. 
Loss of any of these proteins, Plk4, STIL, Sas-6, or 
CEP164, blocks centriole elongation and sequen-
tially inhibits centrosome duplication. Conversely, 
overexpression of these proteins results in cen-
triole amplification. ATAD5 uses C-terminal 
ATPase and RFC interaction domains to regulate 
PCNA unloading [32] while participating in other 
cellular processes by interacting with other related 
proteins through its N-terminal domain [31,49]. 
Mass spectrometry-based interactome analysis 
showed that ATAD5 is likely to interact with cen-
trosome proteins [50]. Our preliminary mass spec-
trometry analysis also spotted out several proteins 
related to centrosome regulation, including Plk1 
and Aurora B kinase as ATAD5-interacting pro-
teins. Based on these results, ATAD5 that localizes 
at the base of the centriole likely regulates centro-
somal proteins by protein–protein interactions.
ATAD5 has been studied with an emphasis on 
its role as a replisome protein associated with 
DNA replication and repair. ATAD5 is primarily 
detected in Triton X-100 insoluble protein frac-
tions containing chromatin-bound and nuclear 
matrix-bound proteins [31]. Consistently, 
ATAD5 has a putative nuclear localization signal 
sequence at the N-terminal regions [32]. In this 
study, we unexpectedly found that ATAD5 is pre-
sent at the centrosomes. Given that RFC5 is not 
detected at the centrosomes (Figure 1(e)), it is 
possible that ATAD5 takes a different conforma-
tion at the centrosomes compared to when it is in 
a complex with other RLC subunits. It is still not 
clear how the N-terminal domain of ATAD5 is 
structurally located relative to the C-terminal 
domain. Since the N-terminal half of ATAD5 
interacts with many other proteins, binding to 
centrosome-specific proteins might interfere with 
proper nuclear localization or RLC formation. 
ATAD5 immunostaining with purified anti- 
ATAD5 antibody shows clearer signals at the cen-
trosomes than at the nucleus (Figure 1). It is likely 
that the polyclonal antibodies raised against the 
N-terminal portion of ATAD5 do not have good 
accessibility to ATAD5 when it forms the RLC 
complex, but instead, efficiently binds to ATAD5 
when it exists as a non-complex at the centro-
somes. The N-terminal region of ATAD5 likely 
plays an important role in its localization to the 
centrosome, independent of RLC, and further, 
regulates centrosome biology through its unique 
conformation.
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